Summit Therapeutics Inc. (SMMT)
24.56
-1.57 (-6.01%)
At close: Apr 15, 2025, 3:59 PM
24.29
-1.10%
Pre-market: Apr 16, 2025, 09:08 AM EDT
Summit Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Buy
Price Target
33.5
Upside
36.40
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Citigroup | Strong Buy | Upgrades | 23 35 | 42.51% | Mar 26, 2025 | |
| Cantor Fitzgerald | Buy | Initiates | n/a | n/a | Mar 21, 2025 | |
| Evercore ISI Group | Buy | Initiates | 30 | 22.15% | Mar 12, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.